SINOMED

medical devices

About

SINOMED is a global medical technology company founded in 2007 and headquartered in Tianjin, China. The company specializes in the research, development, production, and distribution of advanced interventional medical devices, focusing on cardiovascular and neurovascular treatments, as well as structural heart disease. SINOMED is publicly traded on the Shanghai STAR market. The company offers a range of high-end interventional medical devices, including the HT Supreme drug-coated coronary stent system, the NOVA DES intracranial drug-eluting stent system, and the AccuFit transapical mitral valve replacement system. SINOMED serves a global market, with a strong presence in China and expanding operations in the United States. Its customers include hospitals and healthcare providers specializing in interventional cardiology and neurovascular treatment. SINOMED is committed to advancing healthcare innovation and enhancing the global influence of "Made in China" medical products.

Technologies

Microsoft Office 365 Baidu Ads Apache WordPress.org OpenSSL Mobile Friendly

Keywords

rd innovation drugeluting stents cardiology mitral valve replacement device superior quality products rampd neurointervention internationalization medical equipment manufacturing structural heart disease cardiovascular devices device approval process device development minimally invasive treatment regulatory approval product commercialization healthcare technology medical device research biomedical engineering intracranial stent interventional neurology b2b interventional medicine cardiovascular disease treatment medical device certification transcatheter mitral valve replacement interventional cardiology neurointerventional devices medical research

Location

Tianjin, Tianjin, China

Related Companies

Companies in the same industry